Mold-Tek Packaging

Pharma Packaging And FMCG Expansion Will Ignite Future Value

AnalystConsensusTarget

Not Invested

Based on Analyst Price Targets

Published

14 Feb 25

Updated

01 May 25

n/a

AnalystConsensusTarget's Fair Value

n/a

-16.6%

-2.0%

-16.6%

-2.0%

You can edit this narrative until May 12 5:59 AM. Then, changes will post as Updates.

Author's Valuation

₹957.6740.3% undervalued

AnalystConsensusTarget Fair Value

Narrative

Updates8

Shared on 01 May 25

Fair value Increased 21%

Shared on 23 Apr 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on 17 Apr 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on 09 Apr 25

Fair value Decreased 0.90%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on 02 Apr 25

Fair value Increased 3.38%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on 26 Mar 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on 19 Mar 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on 13 Mar 25

Fair value Decreased 1.26%

AnalystConsensusTarget has decreased future PE multiple from 39.3x to 34.9x.

AnalystConsensusTarget Fair Value

₹957.67

40.3% undervalued

Future estimation in

% p.a.

Decrease

Increase

Current revenue growth rate

13.03%

Packaging revenue growth rate

0.15%

Risk Level (Discount Rate)

Our default considers factors like the company's size, volatility, profitablity and country of operation.

Decrease

Increase

Current discount rate

12.76%

Calculation

₹1.36b

Earnings '28

33.26x

PE Ratio '28

₹45.27b

Market Cap '28

₹45.27b

Market Cap '28

33.30m

No. shares '28

₹1.36k

Share Price '28

₹1.36k Share Price '28

Discounted to 2025 @ 12.73% p.a.

₹949.06

Fair Value '25